Stock Rich List
#14596 on the rich list of 14,644 insiders

Matthew L. Posard

Director at Halozyme Therapeutics; Director at Nautilus Biotechnology. Based in San Diego, California.

$4.8M
in disclosed stock, −$173K (−3.45%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
14596th of 14,644
Companies held
2
Largest holding
HALO, 93.3% of total
Latest SEC filing
Nov 18, 2026

What the $4.8M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Halozyme Therapeutics HALO
Common Stock
Directly48,609$93.04$4.5M93.3%Form 4, Nov 18, 2026
Nautilus Biotechnology NAUT
Common Stock
Indirectly (see filing footnote)100,000$2.17$217K4.5%Form 4, Nov 30, 2021
Nautilus Biotechnology NAUT
Common Stock
Directly50,000$2.17$109K2.2%Form 4, Dec 1, 2021

Share counts are the amounts Matthew L. Posard reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 18, 2026SoldHALO3,400$96.17$327KView
Nov 18, 2026SoldHALO1,600$96.97$155KView
Oct 1, 2026SoldHALO730$107.17$78KView
Oct 1, 2026SoldHALO3,300$108.45$358KView
Oct 1, 2026SoldHALO1,100$109.57$121KView
Oct 1, 2026SoldHALO100$110.04$11KView
Sep 16, 2026SoldHALO3,000$106.83$320KView
Sep 16, 2026SoldHALO8,896$108.04$961KView
Sep 16, 2026SoldHALO3,100$106.13$329KView
Sep 16, 2026SoldHALO4,000$108.99$436KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
14593Horne Edward Van
President & COO, GMR Solutions. Lewisville, TX
$4.9M−$340K (−6.54%)
14594Jula Inrig
EVP, Head of R&D & CMO, Travere Therapeutics. San Diego, CA
$4.9M−$195K (−3.86%)
14595Christopher L. Finazzo
Chief Commercial Officer, United Parks & Resorts. Orlando, FL
$4.9M−$162K (−3.23%)
14596Matthew L. Posard
Director, Halozyme Therapeutics. San Diego, CA
$4.8M−$173K (−3.45%)
14597Edward W. Rabin
Director, Sally Beauty Holdings. Denton, TX
$4.8M−$217K (−4.30%)
14598Jerry C. Jones
Director, Agilysys. Alpharetta, GA
$4.8M−$327K (−6.33%)
14599Craig Saldanha
Chief Product Officer, Yelp. San Francisco, CA
$4.8M−$373K (−7.15%)

Other Halozyme Therapeutics insiders

All HALO insiders

Questions

How much stock does Matthew L. Posard own?

Matthew L. Posard holds $4,848,081 in listed stock based on SEC filings and current prices, mostly Halozyme Therapeutics (HALO). That ranks 14596th on the Stock Rich List.

Is this Matthew L. Posard's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Matthew L. Posard last buy or sell stock?

The most recent open-market trade on file is a sale of 3,400 HALO shares on Nov 18, 2026 at $96.17.